AC Immune and Takeda Sign Exclusive Option and License Agreement
资讯
2024-05-18
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease
− Takeda to receive exclusive option to license global right...